GGrantIndex
← Leaderboards

Oklahoma Medical Research Foundation

Oklahoma City, OK

Compare ↔
$672,434,965
Total funding
702
Grants

Funding over time

peak $53.1M · FY2005–25
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$662,766,151 · 687
DOD$5,672,731 · 9
NSF$3,996,083 · 6

By mechanism

R01$295,553,017 · 152
P20$100,910,567 · 244
U19$61,169,109 · 63
P30$35,204,583 · 34
P01$25,794,486 · 21
R35$21,150,692 · 11

Investigators at Oklahoma Medical Research Foundation

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1David Casero$1,088,9521 gr2Ana Julia Chucair-Elliott$521,4041 gr3Bojing Shao$475,7001 gr4Rafal Donczew$468,8751 gr

Emerging Leaders

6–10 yrs in

1Gaurav K Varshney$3,399,4895 gr2Jacquelyn Gorman$3,130,6791 gr3Wan Hee Yoon$2,172,2011 gr4Jian Li$2,148,9431 gr5Chi Fung Lee$1,854,7211 gr6Meng Zhao$1,843,1751 gr7Pengchun Yu$1,748,0001 gr8Bumsoo Ahn$839,4661 gr

All-Time

Most funded here, all years

1Swapan K Nath$17,899,31614 gr2Andrew Scott Weyrich$17,047,72812 gr3Xiao-Hong Sun$13,038,7178 gr4Benjamin Francis Miller$11,325,62910 gr5Florea Lupu$11,138,41510 gr6Lijun Xia$10,496,4785 gr7Paul Wayne Kincade$9,676,2786 gr8Courtney T Griffin$9,616,1795 gr

Largest grants

Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$7,289,569
UC2 · FY2023 · AR
Oklahoma Medical Research Foundation Clinical Research Construction$7,030,924
C06 · FY2010 · RR
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$5,050,000
UC2 · FY2022 · AR
Analysis and Characterization of Trauma-Induced Coagulopathy$4,800,000
UM1 · FY2016 · HL
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$3,700,000
UC2 · FY2024 · AR
Functional and Mechanistic Characterization of Lupus Susceptibility$3,364,935
R01 · FY2025 · AI
Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus$3,130,679
R01 · FY2025 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,991,269
U19 · FY2010 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,986,968
U19 · FY2009 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,910,854
U19 · FY2014 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2017 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2018 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2015 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,898,581
U19 · FY2016 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,840,289
U19 · FY2011 · AI
Expanding Excellence in Developmental Biology in Oklahoma$2,820,000
P20 · FY2013 · GM
Molecular and Immunologic Analysis of the Pathobiology of Anthrax$2,818,251
U19 · FY2005 · AI
Molecular Mechanisms and Genetics of Autoimmunity$2,777,249
P20 · FY2004 · RR
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,776,772
U19 · FY2012 · AI
Molecular and Immunologic Analysis of the Pathobiology of Anthrax$2,760,181
U19 · FY2004 · AI